MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$32,610K
Net Income
$3,290K
Net Profit Margin
10.09%
EPS
$0.24
Unit: Thousand (K) dollars
Revenue Breakdown
OEMChannel
Commercial Channel
Revenue Breakdown
US
Europe
Other Location
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
32,610
29,612
28,766*
27,817
Cost of revenue
11,366
10,615
9,879*
12,233
Gross profit
21,244
18,997
18,887*
15,584
Research & development
7,341
6,713
5,882*
6,946
Selling, general & administrative
10,949
17,772
12,937*
11,871
Total operating expenses
18,290
24,485
18,818*
18,817
Income (gain) from operations
2,954
-5,488
69*
-3,233
Interest and other income, net
426
667
-72*
997
Income (loss) before income taxes
3,380
-4,821
-4*
-2,236
Provision for income taxes
71
235
-1,758*
939
Income (gain) from continuing operations
3,309
-5,056
1,754*
-3,175
Income (loss) from discontinued operations, net of tax
0
0
-3,185*
846
Net income (loss)
3,309
-5,056
-1,431*
-2,329
Foreign currency translation adjustment
-19
-351
78*
-184
Comprehensive income (loss)
3,290
-5,407
-1,353
-2,513
Basic EPS
0.25
-0.37
-0.095
-0.16
Diluted EPS
0.24
-0.37
-0.096
-0.16
Basic Average Shares
13,330,000
13,531,000
14,234,000
14,419,000
Diluted Average Shares
13,717,000
13,531,000
14,081,000
14,419,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
OEMChannel
$18,705K
Commercial Channel
$13,905K
Revenue
$32,610K
(15.56%↑ Y/Y)
Gross profit
$21,244K
(47.91%↑ Y/Y)
Cost of revenue
$11,366K
(-17.97%↓ Y/Y)
Income (gain) from
operations
$2,954K
(170.67%↑ Y/Y)
Interest and other
income, net
$426K
(99.07%↑ Y/Y)
Total operating
expenses
$18,290K
(-1.36%↓ Y/Y)
Income (loss) before
income taxes
$3,380K
(185.22%↑ Y/Y)
Selling, general &
administrative
$10,949K
(-10.47%↓ Y/Y)
Research & development
$7,341K
(16.28%↑ Y/Y)
Income (gain) from
continuing operations
$3,309K
(171.21%↑ Y/Y)
Provision for income taxes
$71K
(-89.57%↓ Y/Y)
Net income (loss)
$3,309K
(183.35%↑ Y/Y)
Comprehensive income (loss)
$3,290K
(225.48%↑ Y/Y)
Foreign currency
translation adjustment
-$19K
(-101.41%↓ Y/Y)
Buy us a coffee
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)